Search results
Jul 17, 2018 · By John D. Hainsworth, MD, and F. Anthony Greco, MD. Cancer of unknown primary site (CUP) is a clinical syndrome that includes many different cancer types and accounts for approximately 2% of all cancer diagnoses.
John D. Hainsworth, MD, of the Sarah Cannon Research Institute, discusses early findings from this umbrella basket study on targeted treatment, outside of current drug indications, for different types of advanced solid tumors (Abstract LBA11511).
Nov 16, 2023 · Based in Nashville, the Greco-Hainsworth Tennessee Oncology Centers for Research is named to honor Drs. Anthony Greco and John Hainsworth, who as part of Tennessee Oncology, founded Sarah Cannon Research Institute in 1993 and changed cancer research by beginning a legacy of expanding access to clinical trial options in community oncology ...
Jul 16, 2024 · In this report from ASCO 2004, John D. Hainsworth, MD, discusses the latest advances in the treatment of non-Hodgkin's lymphoma.
Jun 5, 2016 · John D. Hainsworth, MD, co-founder; principal investigator, Sarah Cannon Research Institute, discusses the results of the MyPathway trial, which was an open-label, phase IIa basket study...
Aug 4, 2022 · Two academic research leaders, Dr. Anthony Greco and Dr. John Hainsworth, had a solution: start a research program in the community, where more people could access more trial options. In 1993, they formed what is now known as Sarah Cannon Research Institute, with the backing of HCA Healthcare and Tennessee Oncology.
Dr. John D. Hainsworth is a Oncologist in Nashville, TN. Find Dr. Hainsworth's phone number, address, insurance information, hospital affiliations and more.
